Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Journey Medical (DERM) Return on Invested Capital (2021 - 2025)

Journey Medical (DERM) has disclosed Return on Invested Capital for 4 consecutive years, with 0.21% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Invested Capital changed N/A year-over-year to 0.21%, compared with a TTM value of 0.21% through Sep 2025, changed N/A, and an annual FY2024 reading of 0.34%, down 29.0% over the prior year.
  • Return on Invested Capital was 0.21% for Q3 2025 at Journey Medical, down from 0.08% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 2.61% in Q3 2021 and bottomed at 2.33% in Q4 2021.
  • Average Return on Invested Capital over 4 years is 0.38%, with a median of 0.64% recorded in 2022.
  • Peak annual rise in Return on Invested Capital hit 172bps in 2022, while the deepest fall reached -331bps in 2022.
  • Year by year, Return on Invested Capital stood at 2.33% in 2021, then skyrocketed by 74bps to 0.61% in 2022, then skyrocketed by 86bps to 0.08% in 2023, then crashed by -145bps to 0.21% in 2025.
  • Business Quant data shows Return on Invested Capital for DERM at 0.21% in Q3 2025, 0.08% in Q4 2023, and 0.73% in Q3 2023.